Cargando…
Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway
Premature ovarian failure (POF) is a condition affecting 1% of women in the general population, causing amenorrhea, hypergonadotropism and hypoestrogenism before the age of 40. Currently, POF cannot be reversed and, although treatments are available, there is an urgent need for improved treatment st...
Autores principales: | LIU, TE, WANG, SUWEI, ZHANG, LINA, GUO, LIHE, YU, ZHIHUA, CHEN, CHUAN, ZHENG, JIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906989/ https://www.ncbi.nlm.nih.gov/pubmed/27347041 http://dx.doi.org/10.3892/etm.2016.3326 |
Ejemplares similares
-
Telocytes as potential targets in a cyclophosphamide-induced animal model of premature ovarian failure
por: Liu, Te, et al.
Publicado: (2016) -
Transplantation of ovarian granulosa-like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure
por: LIU, TE, et al.
Publicado: (2016) -
CD44+/CD105+ Human Amniotic Fluid Mesenchymal Stem Cells Survive and Proliferate in the Ovary Long-Term in a Mouse Model of Chemotherapy-Induced Premature Ovarian Failure
por: Liu, Te, et al.
Publicado: (2012) -
Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure
por: Wang, Fangyuan, et al.
Publicado: (2013) -
Signaling pathway intervention in premature ovarian failure
por: Bai, Xuefeng, et al.
Publicado: (2022)